MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 161 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $684,711 | +24.7% | 2,444 | +18.8% | 0.00% | 0.0% |
Q1 2024 | $549,301 | +17.2% | 2,057 | +1.6% | 0.00% | 0.0% |
Q4 2023 | $468,545 | +57.3% | 2,025 | -0.7% | 0.00% | +100.0% |
Q3 2023 | $297,776 | -26.5% | 2,039 | +16.2% | 0.00% | -50.0% |
Q2 2023 | $405,405 | +2.5% | 1,755 | +7.5% | 0.00% | 0.0% |
Q1 2023 | $395,611 | -11.4% | 1,633 | +6.1% | 0.00% | 0.0% |
Q4 2022 | $446,695 | +329.5% | 1,539 | -3.4% | 0.00% | +100.0% |
Q3 2022 | $104,000 | -8.8% | 1,593 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $114,000 | -28.8% | 1,593 | -2.0% | 0.00% | 0.0% |
Q1 2022 | $160,000 | +49.5% | 1,626 | +29.2% | 0.00% | 0.0% |
Q4 2021 | $107,000 | +7.0% | 1,259 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $100,000 | -18.7% | 1,259 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $123,000 | -16.3% | 1,259 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $147,000 | +5.0% | 1,259 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $140,000 | -6.0% | 1,259 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $149,000 | +4.2% | 1,259 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $143,000 | +320.6% | 1,259 | +150.8% | 0.00% | – |
Q1 2020 | $34,000 | -26.1% | 502 | 0.0% | 0.00% | – |
Q4 2019 | $46,000 | +7.0% | 502 | 0.0% | 0.00% | – |
Q3 2019 | $43,000 | -18.9% | 502 | 0.0% | 0.00% | – |
Q2 2019 | $53,000 | -15.9% | 502 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $63,000 | +10.5% | 502 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $57,000 | -46.7% | 502 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $107,000 | -23.6% | 502 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $140,000 | – | 502 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |